Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy
Rosa Fernandes, Sofia Viana, Sara Nunes, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2018) Vol. 1865, Iss. 7, pp. 1876-1897
Open Access | Times Cited: 140

Showing 1-25 of 140 citing articles:

Beneficial Effects of Dietary Polyphenols on Gut Microbiota and Strategies to Improve Delivery Efficiency
Amit Kumar Singh, Célia Cabral, Ramesh Kumar, et al.
Nutrients (2019) Vol. 11, Iss. 9, pp. 2216-2216
Open Access | Times Cited: 353
Role of the gut microbiota in type 2 diabetes and related diseases
Ge Yang, Jinlong Wei, Pinyi Liu, et al.
Metabolism (2021) Vol. 117, pp. 154712-154712
Closed Access | Times Cited: 293
The Role of Inflammation in Diabetic Retinopathy
John V. Forrester, Lucia Kuffová, Mirela Delibegović
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 288
Gut Microbiota and Complications of Type-2 Diabetes
Camelia Oana Iatcu, Aimee Steen, Mihai Covașă
Nutrients (2021) Vol. 14, Iss. 1, pp. 166-166
Open Access | Times Cited: 268
ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities – Role of gut microbiota dysbiosis
Sofia Viana, Sara Nunes, Flávio Reis
Ageing Research Reviews (2020) Vol. 62, pp. 101123-101123
Open Access | Times Cited: 172
The Role of the Gut Microbiome in Diabetes and Obesity-Related Kidney Disease
Amgad Zaky, Sarah Glastras, May Wong, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9641-9641
Open Access | Times Cited: 127
Beneficial Effects of Phenolic Compounds on Gut Microbiota and Metabolic Syndrome
Kamila Kasprzak‐Drozd, Tomasz Oniszczuk, Mateusz Stasiak, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3715-3715
Open Access | Times Cited: 126
Causal effects of gut microbiota on diabetic retinopathy: A Mendelian randomization study
Kangcheng Liu, Jing Zou, Huimin Fan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 93
Synergic interactions between polyphenols and gut microbiota in mitigating inflammatory bowel diseases
Hao Li, Lindsey M. Christman, Ruiqi Li, et al.
Food & Function (2020) Vol. 11, Iss. 6, pp. 4878-4891
Closed Access | Times Cited: 112
Gut microbiome, prebiotics, intestinal permeability and diabetes complications
Matthew Snelson, Cassandra de Pasquale, Elif I. Ekinci, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2021) Vol. 35, Iss. 3, pp. 101507-101507
Closed Access | Times Cited: 102
Involvement of Gut Microbiota, Microbial Metabolites and Interaction with Polyphenol in Host Immunometabolism
Andy W. C. Man, Yawen Zhou, Ning Xia, et al.
Nutrients (2020) Vol. 12, Iss. 10, pp. 3054-3054
Open Access | Times Cited: 98
Dysbiosis of intestinal microbiota mediates tubulointerstitial injury in diabetic nephropathy via the disruption of cholesterol homeostasis
Ze Bo Hu, Jian Lü, Pei Pei Chen, et al.
Theranostics (2020) Vol. 10, Iss. 6, pp. 2803-2816
Open Access | Times Cited: 81
The Intestinal Microbiota: Impacts of Antibiotics Therapy, Colonization Resistance, and Diseases
Taif Shah, Zulqarnain Baloch, Zahir Shah, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6597-6597
Open Access | Times Cited: 74
Hyperglycaemia‐associated macrophage pyroptosis accelerates periodontal inflamm‐aging
Pengfei Zhao, Ziqi Yue, Lulingxiao Nie, et al.
Journal Of Clinical Periodontology (2021) Vol. 48, Iss. 10, pp. 1379-1392
Closed Access | Times Cited: 68
Alteration of gut microbial profile in patients with diabetic nephropathy
Xi Du, Jia Liu, Xue Yu, et al.
Endocrine (2021) Vol. 73, Iss. 1, pp. 71-84
Closed Access | Times Cited: 65
Evolving Interplay Between Dietary Polyphenols and Gut Microbiota—An Emerging Importance in Healthcare
Suman Kumar Ray, Sukhes Mukherjee
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 64
Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19 via Cytokine Storm?
Ramachandran Vignesh, Chinnambedu Ravichandran Swathirajan, Zaw Htet Tun, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 62
Gut Microbiome in Retina Health: The Crucial Role of the Gut-Retina Axis
Gianluca Scuderi, Emidio Troiani, Angelo Maria Minnella
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 49
A Review of Traditional Chinese Medicine on Treatment of Diabetic Nephropathy and the Involved Mechanisms
Xiaojuan Liu, Xiangka Hu, He Yang, et al.
The American Journal of Chinese Medicine (2022) Vol. 50, Iss. 07, pp. 1739-1779
Closed Access | Times Cited: 49
Microbiota and COVID-19: Long-term and complex influencing factors
Jiaqi Gang, Haiyu Wang, Xiangsheng Xue, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 48
Possible cancer-causing capacity of COVID-19: Is SARS-CoV-2 an oncogenic agent?
Kasra Jahankhani, Fatemeh Ahangari, Ian M. Adcock, et al.
Biochimie (2023) Vol. 213, pp. 130-138
Open Access | Times Cited: 33
Gut microbiota and its metabolites – molecular mechanisms and management strategies in diabetic kidney disease
Zi‐Hui Mao, Zhong‐Xiuzi Gao, Dongwei Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Contribution of extracellular vesicles for the pathogenesis of retinal diseases: shedding light on blood-retinal barrier dysfunction
Beatriz Martins, Maria E. Pires, António Francisco Ambrósio, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 14
Causal relationship between gut microbiota and diabetic nephropathy: a two-sample Mendelian randomization study
Shuxiang Yan, Hua Wang, Baiyu Feng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Emerging Vistas for the Nutraceutical Withania somnifera in Inflammaging
Vivek Basudkar, Gunjan Gujrati, Saiprasad Ajgaonkar, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 597-597
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top